Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Medical and industry groups oppose Board's therapeutic-interchange proposal, cite patient-safety risks
Summary
Pharmaceutical industry groups and psychiatrists told the committee a board proposal to allow pharmacist-initiated therapeutic interchange could endanger patients and disrupt the physician-patient relationship; speakers urged rejection or substantial guardrails.
Representatives of the pharmaceutical industry and physician specialty groups warned legislators that a Board of Pharmacy proposal discussed in the board's report could permit pharmacists to effect therapeutic interchange without prior physician authorization, a change they said could put patients at risk.
Fred Notewear of the Pharmaceutical Research and Manufacturers of America (PhRMA) urged rejection of proposed changes to Business and Professions Code language,…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
